Press Release

Illumina to Present at Upcoming Investment Conferences in November

SAN DIEGO, Nov 09, 2010 (BUSINESS WIRE) -- Illumina, Inc. (NASDAQ:ILMN) today announced that the company will webcast its presentations at two upcoming investment conferences.

Illumina will webcast its presentation at the Citi Small/Mid Cap Conference in Las Vegas, Nevada, on Tuesday, November 16, 2010. The live webcast is scheduled to begin at 1:55 p.m. ET and will feature a brief overview of the company by Christian Henry, Senior Vice President, Chief Financial Officer and General Manager of Life Sciences, followed by a question and answer session.

Illumina will also webcast its presentation at the Piper Jaffray "Unplugged" Healthcare Conference in New York, New York, on Tuesday, November 30, 2010. The live webcast is scheduled to begin at 2:30 p.m. ET and will feature a brief overview of the company by Christian Henry, followed by a question and answer session.

These live webcasts can be accessed under the "Corporate/Investor Information" tab of Illumina's web site at www.illumina.com.

About Illumina

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.

SOURCE: Illumina, Inc.

Illumina, Inc.
Investors:
Peter J. Fromen
Sr. Director, Investor Relations
+858-202-4507
pfromen@illumina.com
or
Media:
Wilson Grabill
Sr. Manager, Public Relations
+858-882-6822
wgrabill@illumina.com

Recent Articles

Early access users rave about Illumina’s new MiSeq i100 Series
Early access users rave about Illumina’s new MiSeq i100 Series
Trailblazing study shows early CGP leads to better precision treatments
Trailblazing study shows early CGP leads to better precision treatments
How two systems integration scientists ensure a smooth workflow on MiSeq i100
How two systems integration scientists ensure a smooth workflow on MiSeq i100